Scenarios of impact of Coronavirus on Injection Pen Market

The ongoing COVID-19 pandemic—and the worldwide reaction to it—has compelled companies to radically rethink their strategies and the way they operate. We salute the industry experts helping companies survive and sustain in this pandemic.

At MarketsandMarkets™, analysts are undertaking continuous efforts to provide analysis of the COVID-19 impact on the Injection Pen Market. We are working diligently to help companies take rapid decisions by studying: 

• The impact of COVID-19 on the Injection Pen Market, including growth/decline in product type/use cases due to the cascaded impact of COVID-19 on the extended ecosystem of the market 
• The rapid shifts in the strategies of the Top 50 companies in the Injection Pen Market 
• The shifting short-term priorities of the top 50 companies’ clients and their client’s clients 

You can request an in-depth analysis detailing the impact of COVID-19 on the Injection Pen Market: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=42342539

According to the new market research report “Injection Pen Market by Type (Disposable and Reusable Pens), Therapy (Diabetes (Insulin, Glucagon-Like Peptide-1), Growth Hormone Therapy, Osteoporosis, Fertility), End User (Homecare and Hospitals), and Region — Global Forecast to 2022”, published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).

Don’t miss out on business opportunities in Injection Pen Market.
The growth of this market is primarily driven by factors such as the growing prevalence of chronic diseases, increasing number of regulatory approvals, and favorable reimbursement in developed countries, and government support.

The market is segmented on the basis of type, therapy, end user, and region. Based on type, the market is segmented into disposable and reusable injection pens. The disposable injection pens segment is expected to grow at the highest CAGR during the forecast period. The high growth of this segment can be attributed to the benefits disposable pens offer, such as portability, ease of use, and low possibility of infection.

Browse and in-depth TOC on “ Injection Pen Market “
109 — Tables
36 — Figures
185 — Pages
Download an Illustrative overview of the report — https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=42342539

The home care segment dominated the market on the basis of end users in 2017

The injection pen market is segmented on the basis of end users into home care and hospital & clinics. In 2017, homecare segment accounted for the largest share of the global market. Majority of injection pens are used for self-administration of drugs, and are rarely recommended for hospital use to avoid the risk of infection due to use on multiple patients. Factors such as the growing prevalence of chronic diseases and technological advancements are driving the growth of this segment.

North America held the largest share of the market in 2017

In 2017, North America accounted for the largest share of the injection pen market, followed by Europe. Factors such as increasing geriatric population in Canada, increasing FDA approvals, and rising prevalence of chronic diseases in the US and Canada are contributing to the large share of this geographical segment.

Request for Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=42342539

Key Players

The key players in the global injection pen market are Novo Nordisk (Denmark), Eli Lilly (US), Sanofi (France), Ypsomed (Switzerland), Merck (Germany), AstraZeneca (UK), F. Hoffman-la Roche (Switzerland), Becton, Dickinson and Company (US), Owen Mumford (UK), Novartis (Switzerland), Pfizer (US), and Haselmeier (Switzerland).